April 16, 2024 News by Marisa Wexler, MS Patients deem AI-based ChatGPT more empathetic than neurologists When presented with medical information authored by neurologists or by ChatGPT, people with multiple sclerosis (MS) reported similar satisfaction with both, but said the artificial intelligence platform was more empathetic. That’s the result of the study, “ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings…
July 26, 2023 News by Marisa Wexler, MS AI model is able to predict MS risk years before disease onset A new artificial intelligence (AI) algorithm could help identify people at risk of developing multiple sclerosis (MS). “Our model’s performance suggests that AI-based prediction models could identify the risk for multiple sclerosis years before neurological symptoms appear,” Raj Gopalan, MD, a scientist at Siemens Healthineers, Tarrytown, New York, said…
October 3, 2022 News by Mary Chapman Cionic Nets $12.5M to Develop AI-powered Mobility Garments Bionic clothing innovator Cionic has received $12.5 million to further develop a platform that produces wearable, artificial intelligence-powered garments for people with mobility issues. The platform has helped create the Neural Sleeve, a leg-worn garment that enables people with conditions such as multiple sclerosis (MS) to become more…
October 12, 2021 News by Patricia Inacio, PhD Innodem, Novartis Team Up on Trial Testing Eye-tracking Technology Innodem Neurosciences is teaming up with Novartis Canada on a breakthrough clinical trial to evaluate if Innodemās digital biomarker eye-tracking technology can monitor disease progression in people with multiple sclerosis (MS). The trial will test Innodem’s “easy-to-use, affordable technology,” which works using visible light, with no special infrared…
May 10, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Early MS, Fenebrutinib, Restless Legs, Safer MRIs Phase 4 Trial Will Test if Ocrevus Can Prevent MS Onset in RIS Patients Yes, you’re reading this right. This trial aims to see if Ocrevus can stop MS before it’s officially diagnosed ā when it may be smoldering and presenting a minimum of MS-like activity. In July, this…
May 6, 2021 News by Margarida Maia, PhD US Patent Issued for Software That Could Make MRI Scans Safer Subtle MedicalĀ announced the granting of a U.S. patent for its radiology software that uses artificial intelligence to improve the quality of medical imaging, with the potential to reduce the amount of gadolinium, a contrast agent, needed to one-tenth of its usual dose. Gadolinium, a heavy metal, is included in…
April 30, 2021 News by Forest Ray PhD MS Society of Canada Grant to Support AI in Predicting Disease Course The Multiple Sclerosis Society of Canada has awarded CA$1 million to a project helping doctors who treatĀ multiple sclerosis (MS) patients make more personalized treatment decisions through the use of artificial intelligence (AI). The society awarded the five-year grant (worth about $814,800) to Douglas Arnold, MD, a neurologist with…
February 8, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Plegridy, Telemedicine, AI for MS, Myelin Repair FDA Approves Plegridy as Intramuscular Injection for Relapsing MS A common patient complaint about Plegridy has been that its subcutaneous injection procedure results in injection site reactions. This new formulation is delivered into the muscle, rather than under the skin. The needle is longer, but Biogen pharmaceuticals thinks the…
February 2, 2021 News by Teresa Carvalho, MS European Project Uses Artificial Intelligence to Help Improve Patient Care The recently launched BRAINTEASER project focuses on the use of artificial intelligence (AI) technology to improve the care of patients with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). An initiative of a European consortium, BRAINTEASER could benefit patients, caregivers, and clinicians by enhancing the ability to predict,…
September 4, 2020 Columns by Ed Tobias Amazon’s Halo Judges Your Stress by Listening to Your Voice You’re stressed, and Halo may know it. Halo is a new Amazon service the company says can judge how stressed you are, in part by the tone of your voice. The service uses a wristband that connects to a mobile app. A small sensor in the band monitors temperature, heart…
November 15, 2019 Columns by Ed Tobias Is It Good that Google Is Crunching Our Healthcare Data? Google has quietly teamed up with Ascension, one of the largest healthcare organizations in the United States, to process the medical records of millions of people. According to The Wall Street Journal, “Project Nightingale” involves all sorts of information about things like lab results,Ā diagnoses, and hospitalization records, and…
June 17, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: DMT Strategy Study, MS and Genetic Mutations, MS Art Project, AI Helps Neuros Read MRIs DELIVER-MS Trial Recruiting RRMS Patients to Help Improve Treatment Decision-making What’s the best way to attack multiple sclerosis when it’s first diagnosed? Do you hit it hard and fast using the most effective disease-modifying therapy (DMT), or do you start with a lower efficacy DMT and slowly ramp up?…
June 14, 2019 News by Joana Carvalho, PhD New AI Method Detects Brain Changes in Response to Treatment in RRMS Patients A new artificial intelligence (AI)-based model is better than conventional methods for detecting brain changes in response to treatment with Tysabri (natalizumab) in patients with relapsing-remitting multiple sclerosis (RRMS), a study reports. The study, “High-dimensional detection of imaging response to treatment in multiple sclerosis,” was published in…